CVS Health (CVS) PT Lowered to $112 at UBS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $93.47 -1.07%
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Join SI Premium – FREE
UBS analyst Kevin Caliendo lowered the price target on CVS Health (NYSE: CVS) to $112.00 (from $118.00) while maintaining a Buy rating.
You May Also Be Interested In
- Coforge Ltd (COFORGE:IN) PT Raised to INR2,460 at UBS
- Lockheed Martin (LMT) PT Raised to $692 at UBS
- Boyd Gaming (BYD) PT Lowered to $80 at StoneX
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
